Prof. Dr. Meinrad Beer, Director of the Clinic for Diagnostic and Interventional Radiology, University Hospital Ulm

Prof. Meinrad Beer

mint Lesion™ has become an indispensable part of our tumor boards and clinical trials. It significantly strengthens the recognition of radiology and the cooperation between imaging departments and with clinical partners.

Related Resources

Related Resources

VSRN 2026

02/06 to 02/07/2026 Baden-Baden, Germany

Association of Southwest German Radiologists and Nuclear Medicine Specialists

Standardized response criteria evaluation in mint Lesion featuring the TGRM module.

From Theory to Practice: Evaluating g-values within mint Lesion

Following the FDA’s recent analysis of the growth rate constant (g) as a prognostic marker1, the challenge for many research organizations is…

mint Lesion usage during a clinical trial read, featuring the TGRM export tool.

Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer

For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…